Mustang Bio Statistics
Share Statistics
Mustang Bio has 4.38M
shares outstanding. The number of shares has increased by -90.94%
in one year.
| Shares Outstanding | 4.38M |
| Shares Change (YoY) | -90.94% |
| Shares Change (QoQ) | -94.35% |
| Owned by Institutions (%) | 8.04% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 431 |
| FTD / Avg. Volume | 0.1% |
Short Selling Information
The latest short interest is 199.32K, so 7.56% of the outstanding
shares have been sold short.
| Short Interest | 199.32K |
| Short % of Shares Out | 7.56% |
| Short % of Float | 11.16% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -3.44 and the forward
PE ratio is -0.01.
Mustang Bio's PEG ratio is
0.06.
| PE Ratio | -3.44 |
| Forward PE | -0.01 |
| PS Ratio | 0 |
| Forward PS | 0.1 |
| PB Ratio | -14 |
| P/FCF Ratio | -4.75 |
| PEG Ratio | 0.06 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Mustang Bio.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.68,
with a Debt / Equity ratio of -0.23.
| Current Ratio | 0.68 |
| Quick Ratio | 0.68 |
| Debt / Equity | -0.23 |
| Debt / EBITDA | -0.05 |
| Debt / FCF | -0.08 |
| Interest Coverage | 3249 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-2,625,333.33 |
| Employee Count | 6 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -90.08% in the
last 52 weeks. The beta is 2.27, so Mustang Bio's
price volatility has been higher than the market average.
| Beta | 2.27 |
| 52-Week Price Change | -90.08% |
| 50-Day Moving Average | 1.28 |
| 200-Day Moving Average | 7.86 |
| Relative Strength Index (RSI) | 45.85 |
| Average Volume (20 Days) | 433,250 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -16.25M |
| Net Income | -15.75M |
| EBITDA | -16.25M |
| EBIT | -15.76M |
| Earnings Per Share (EPS) | -2.57 |
Full Income StatementBalance Sheet
The company has 6.84M in cash and 878K in
debt, giving a net cash position of 5.96M.
| Cash & Cash Equivalents | 6.84M |
| Total Debt | 878K |
| Net Cash | 5.96M |
| Retained Earnings | -396.72M |
| Total Assets | 14.91M |
| Working Capital | 3.76M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -11.41M
and capital expenditures 0, giving a free cash flow of -11.41M.
| Operating Cash Flow | -11.41M |
| Capital Expenditures | n/a |
| Free Cash Flow | -11.41M |
| FCF Per Share | -1.86 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
